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ABSTRACT: In asthmatic subjects an imbalance between elastase and a1-antitrypsin
(a1-PI) exists. This study aims to evaluate whether ageing per se affects the levels of
elastase.
Both young and elderly asthmatics with comparable severity and duration of disease,
as well as young and elderly healthy subjects, underwent an induced sputum procedure
to measure levels of elastase and a1-PI.
The percentage of sputum neutrophils and eosinophils was higher in young and
elderly asthmatics than in young and elderly controls. The levels of both total and active
elastase were signi cantly higher in young and elderly asthmatics than in young and
elderly controls, and directly correlated with the percentage of neutrophils. In addition,
in both young and elderly asthmatics the levels of total and active elastase were
negatively correlated with forced expiratory volume in one second values, but positively
correlated with the duration of the disease.
This study indicates that ageing per se does not necessarily lead to a progressive
elastase/a1-antitrypsin imbalance in asthma, and suggests that an important variable in
the development of airway remodelling in both young and elderly asthmatics is
represented by the duration of the disease.
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Bronchial asthma is commonly considered a disease of
the young; however, epidemiological evidence indicates that
asthma is not rare in elderly subjects [1]. One of the most
important characteristics of ageing lung is the loss of elastin
 bres and of elastic recoil [2, 3]. Increased elastin degradation
has been demonstrated in the airways of young mild-to-
moderate and severe asthmatics [4, 5], suggesting that the
elastolytic activity in the bronchial mucosa is enhanced,
possibly because of an imbalance between elastase and a1-
antitrypsin (a1-PI); in addition, the increased levels of active
elastase correlate with the degree of airway obstruction [6],
suggesting a relationship between this biochemical imbalance
and the development of long-term airway modi cations,
which may account for the increased rate of decline in forced
expiratory volume in one second (FEV1) and for the loss of
airway reversibility of bronchial obstruction [7–9]. It is now
well known that in bronchial asthma these changes are the
result of a chronic in ammatory process; conversely, ageing is
accompanied by a subclinical lower respiratory tract in am-
mation, as demonstrated in asymptomatic, clinically normal
volunteers of advanced age [10, 11]. Therefore, ageing and
asthma share, to some extent, some in ammatory and elastolytic
processes; however, it is unclear whether these phenomena
interact in elderly asthmatics.
To better understand whether ageing is associated with a
speci c in ammatory pro le and an altered homeostasis of
elastin in the airways, an evaluation of in ammatory cells,
elastase and a1-PI levels was undertaken in induced sputum of
young and elderly asthmatics matched for duration of the
disease, degree of baseline FEV1 and response to salbutamol.
Two groups of young and elderly healthy subjects that
matched asthmatics in terms of age acted as internal controls.
Methods
Subjects
Eleven young control subjects (median age 27, 25th to 75th
percentiles 27–32 yrs), 10 elderly control subjects (67.5,
61–71 yrs), 22 young asthmatics (32.5, 24–45 yrs) and 10
elderly asthmatic patients (72, 67–75 yrs) were studied.
Asthma was diagnosed on the basis of criteria as described
previously [12]. To avoid any potential inclusion of subjects
with concomitant chronic obstructive pulmonary disease,
only those who showed an improvement of FEV1 of>12%
from baseline or an absolute value of 200 mL following inhala-
tion of 200 mg of salbutamol were included in the study. For
the same purposes, smoking habit was carefully evaluated,
and no current or previous smokers were recruited. According
to a previous study [13], asthmatics were matched for the
duration of the disease, the degree of airway obstruction as
assessed by FEV1, and the degree of reversibility of airway
obstruction (table 1).
Patients were excluded from the study if they had undergone
a severe exacerbation of asthma requiring hospitalisation
during the month preceding the study. Inhaled corticosteroids
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or oral corticosteroids had been withdrawn for at least 2
months prior to the commencement of the study, while the
use of nedocromil sodium or cromoglycate had been stopped
for at least 2 weeks, and theophylline in the previous 48 h.
The study was approved by the appropriate Ethics Committee
and the patients gave informed consent.
Induced sputum production and processing
Induced sputum production and processing were carried
out according to a previously published method [6]. The
safety of sputum induction was carefully assessed during this
study in elderly asthmatics. After processing, the homoge-
nised sputum was centrifuged at 8006g for 10 min to separate
the supernatants from the cell pellet. The supernatants were
frozen at -20°C for subsequent biochemical analysis. The cell
pellet was resuspended in saline solution and the cell viability
was assessed by Trypan blue exclusion. Cytocentrifuged cells
were then stained by Diff Quick1 (Merz-Dade, Dudingen,
Switzerland) for differential cell counts. The slides were
blindly read by counting ù 400 cells per slides by two inde-
pendent investigators. The number of the squamous cells was
subtracted from the total cell counts and the differential cell
counts were expressed as corrected percentage.
Biochemical analysis of sputum
Total elastase was measured by enzyme immunoassay speci c
for human polymorphonuclear elastase (Ecoline; Merck,
Darmstadt, Germany) using the package insert [6, 14]. In
addition, to assess the effect of metalloelastases from bacterial
or macrophages sources on the assay system, the inhibitory
pro le of active elastase was determined by 30 min of
preincubation of the sample with 0.4 mM methoxysuccinyl-
Ala-Ala-Pro-Val-chloromethyl ketone (Sigma Chemical Co.,
St Louis, MO, USA) and 50 mM ethylenediamine tetraacetic
acid (EDTA) [6]. The lower detection limit of the assay was
20 mg?L-1. Neutrophil elastase activity was measured accord-
ing to the technique of Fujita as described previously [9, 15]
using the speci c substrate methoxy-succinyl-Ala-Ala-Pro-
Val-p nitroanilide (Sigma). The lower detection limit of the
assay was 0.04 mg?mL-1. a1-PI in sputum was detected by a
nephelometric assay (Beckman array protein system; Beckman
Instruments, Fullerton, CA, USA) using speci c monoclonal
antibodies [16]. The lower detection limits of the assays were
2.8 mg?mL-1.
Statistical analysis
Results are expressed as median and 25th to 75th per-
centiles. Mann-Whitney U-test was used to assess differences
between groups. Spearman rank correlation was calculated to
evaluate the correlation between outcomes. p-values ø 0.05
were considered signi cant.
Results
Demographic characteristics of the patients
FEV1 values were higher in young than in elderly control
subjects (p<0.003), whereas in asthmatics FEV1 values were
similar in young and elderly subjects. Median FEV1 values in
young asthmatic patients were 84% of predicted values
(73–98%) (table 1) and in elderly asthmatic patients 73.5%
(52–91%). In both young and elderly subjects FEV1 was
inversely correlated with the duration of the disease (p<0.04
and p<0.02, respectively, Spearman rank correlation).
Total and differential cell counts in sputum
The percentage of squamous cells was not signi cantly
different in sputum samples obtained from elderly and young
control and asthmatic subjects (table 2). The corrected median
total cell counts were similar in the four groups. The median
viability of sputum cells was similar in the four study groups
(table 2). The differential counts of sputum cells were similar
in young and elderly control subjects (table 2), except for
neutrophils, whose percentage was higher in the elderly than
in the young (p<0.02), and macrophages whose percentage
was higher in the young than in the elderly (p<0.02).
Conversely, the differential counts of sputum cells were not
statistically different between young and elderly asthmatics.
The percentage of neutrophils and eosinophils was signi -
cantly higher in young asthmatics than in young controls
(p<0.003 and p<0.0001, respectively) as well as in elderly
asthmatics than in elderly controls (p<0.05 and p<0.0003,
respectively; table 2). Finally, in both young and elderly
asthmatics the percentage of neutrophils was directly corre-
lated with the duration of the disease (p<0.002 and p<0.03,
respectively).
Total and active elastase
Total elastase levels were signi cantly higher in young
asthmatics (4.75 (2.6–8.6) mg?mL-1) than in healthy controls
(1.21 (0.9–1.4) mg?mL-1, p<0.001). Similar results were obtained
in elderly asthmatics (4.9 (3.2–10.9) mg?mL-1) when compared
with the control group (1.7 (1.3–2.8) mg?mL-1, p<0.003).
Active elastase levels were 0.96 (0–3.1) mg?mL-1 in young
asthmatics and 1.5 (0.4–2.9) mg?mL-1 in elderly asthmatics,
whereas no levels were detected in the healthy control groups.
Both total and active elastase levels did not differ between the
young and elderly asthmatic groups. Similar comparison
within the healthy control groups did not yield any signi cant
difference ( g. 1). When total and active elastase levels were
Table 1. –Demographic characteristics of patients
YC YA EC EA p-value
YA/EA YC/YA EC/EA YC/EC
Age yrs 27 (27–32) 32.5 (24.0–45.0) 67.5 (61.0–71.0) 72 (67–75)
FEV1 % 100 (98–102) 84 (73–98) 93.5 (88.0–96.0) 73.5 (52.0–91.0) NS <0.009 <0.04 <0.003
Duration# yrs N/A 10 (9–13) N/A 13 (9–15) NS N/A N/A N/A
Data are expressed as median (25–75th percentiles). YC: young controls; YA: young asthmatics; EC: elderly controls; EA: elderly asthmatics; N/A:
not applicable; NS: nonsigni cant. #: of disease. p-values by Mann-Whitney U-test.
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plotted against the percentage of neutrophils, signi cant cor-
relations were found (young asthmatics: total elastase p<0.05,
active elastase p<0.009; elderly asthmatics: total elastase
p<0.02, active elastase p<0.02;  g. 2).
Interestingly, total and active elastase levels also correlated
with the degree of baseline airway narrowing (expressed as
FEV1 % pred), not only in young asthmatics (total elastase
p<0.02, active elastase p<0.003), but also in elderly asth-
matics (total elastase: p<0.03, active elastase: p<0.05;  g. 3).
As shown in  gure 4, similar results were obtained when the
duration of disease was analysed (young asthmatics: total
elastase p<0.004, active elastase p<0.003; elderly asthmatics:
total elastase p<0.006, active elastase p<0.004). Since, in each
group, one subject showed total and active elastase levels
apparently out of range, the analysis was performed again by
taking out the data from those individuals. When FEV1
represented the outcome of the regression, the results of the
analysis did not change for young asthmatics (total elastase
p<0.01, active elastase p<0.003), whereas, for elderly asth-
matics, the relationship became weaker (total elastase p<0.06,
active elastase p<0.18). This leads to the possibility that in
elderly asthmatics air ow limitation is a more complex phe-
nomenon, in which elastase plays a secondary role. Con-
versely, the exclusion of the "outliers" did not change the
signi cant relationship between the levels of elastase (active
and total) and the duration of asthma, further supporting the
role of length of exposition to remodelling changes (for young
asthmatics: total elastase p<0.007, active elastase p<0.005; for
Table 2. –Cell analysis of sputum samples
YC YA EC EA p-value
YA/EA YC/YA EC/EA YC/EC
Squamous cells % 21 (12.0–28.8) 17.4 (12.0–35.1) 28.5 (20.0–36.0) 16.6 (12.0–32.6) NS NS NS NS
Total cell count
6106 cells?mL-1
1.7 (0.8–3.6) 2.1 (1.3–5.0) 1.9 (1.0–2.6) 1.9 (1.3–2.4) NS NS NS NS
Corrected cell counts
6106 cells?mL-1
1.5 (0.6–2.7) 1.6 (0.7–4.0) 1.4 (0.6–2.2) 1.5 (0.9–2.0) NS NS NS NS
Differential cell counts %
Macrophages 84 (80–91) 59.3 (37.0–75.0) 66.5 (59.0–76.0) 47.2 (33.0–64.0) NS <0.0004 <0.03 <0.02
Neutrophils 15 (9–19) 30.1 (23.2–49.0) 32.5 (22.0–40.0) 44.5 (30.0–61.0) NS <0.003 <0.05 <0.02
Lymphocytes 0 (0–0.9) 0 (0–0.5) 0.8 (0–1.0) 0 (0–0.8) NS NS NS NS
Eosinophils 0 2.1 (1.0–2.9) 0 2.8 (1.5–4.3) NS <0.0001 <0.0003 NS
Epithelial cells 0.5 (0–0.9) 1.0 (0–2.1) 1.1 (0–1.5) 2.0 (1.0–2.5) NS NS NS NS
Viability % 81 (70.8–83.0) 69.4 (58.0–80.0) 78 (74–81) 75 (58.0–81.4) NS NS NS NS
Data are expressed as median (25–75th percentiles). YC: young controls; YA: young asthmatics; EC: elderly controls; EA: elderly asthmatics; NS:
nonsigni cant. p-values by Mann-Whitney U-test.
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Fig. 1. – Levels of total elastase and active elastase in sputum obtained from both young (a and c) and elderly (b and d) control (E )
and asthmatic (F ) subjects. Statistical analysis was performed using the Mann-Whitney U-test. ***: p<0.001; #: p<0.003; }: p<0.002.
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Fig. 2. –Correlation between levels of total elastase and active elastase and percentage of neutrophils in sputum obtained from young (a and c)
and elderly (b and d) asthmatic patients. Statistical analysis was performed using Spearman9s rank correlation test: a) rho=0.4, p<0.05; b)
rho=0.8, p<0.02; c) rho=0.6, p<0.009; d) rho=0.8, p<0.02.
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values in young (a and c) and elderly (b and d) asthmatic patients. Statistical analysis was performed using Spearman9s rank correlation test: a)
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elderly asthmatics: total elastase p<0.01, active elastase
p<0.009).
In young and elderly controls, the levels of a1-PI were often
undetectable. In contrast, the levels of a1-PI were not different
in sputum obtained from young and elderly asthmatic
subjects (9 (8–18) versus 8.45 (5–13) mg?mL-1, respectively).
Finally, the ratio of total elastase over a1-PI was pooled
against FEV1 and duration of the disease. The results of this
analysis basically con rm the above-described relationships.
Indeed, the regression analysis showed that the ratio of total
elastase over a1-PI signi cantly correlated with FEV1 (for
young asthmatics p<0.02; for elderly asthmatics p<0.04), and
with duration of disease (for young asthmatics p<0.0001; for
elderly asthmatics p<0.02).
Discussion
The authors have previously demonstrated that elastase levels
are signi cantly increased in asthmatic subjects, suggesting
that this phenomenon could contribute to the occurrence of
remodelling changes in the extracellular matrix of the lung.
However, since the study population consisted of young asth-
matics, the question of whether ageing processes could in uence
the balance between elastase and a1-PI was addressed. Herein,
the authors have shown that the levels of elastase do not
differ between young and elderly asthmatic subjects, and are
often undetectable in elderly, as well as in young, healthy
subjects. Moreover, elastase levels were found to positively
correlate with the duration of asthma and negatively with
FEV1 values, both in young and in elderly asthmatic subjects.
An imbalance between proteinases and their inhibitors has
been reported in individuals with airway in ammation [15],
supporting the concept that this mechanism is a feature of
chronic bronchitis. A wealth of evidence has accumulated to
date to con rm that this phenomenon also occurs in the
airways of asthmatics; indeed, an abnormal elastic  bre
network, in which connective  bres often appear fragmented,
has been demonstrated in this disease [4, 5]. It is reasonable to
expect that the alteration of the elastic  bre network has
important pathophysiological consequences in asthma. Air-
 ow limitation that occurs in asthma can be described as
a complex phenomenon that derives from several factors,
one of which is represented by the elastolytic activity. The
increased elastolytic activity in the airways of asthmatics
could play an important role in the pathogenesis of airway
remodelling and in the development of some functional
abnormalities, such as the exaggerated airway narrowing [17].
This is further supported by several studies in moderate and
severe asthmatics, which show that loss of elastic recoil [18],
the increased collapsability of the central airways in long-
lasting asthma [19], the lack of distensibility of airways [20]
and hyperin ation [21] variably occur. In a recent study,
GELB and ZAMEL [21] have demonstrated the unsuspected
loss of lung elastic recoil in severe asthmatics, which develops
via unknown mechanism(s). Therefore, it is not unlikely that
elastase may induce changes of the elastic  bre network of the
lung of asthmatic subjects, thus affecting lung function, as
shown by the present study.
However, the relationship between air ow obstruction and
structural alterations of the airways cannot be solely attri-
buted to changes in the elastic component. Furthermore, it is
unknown to what extent the pathological abnormalities of the
large and small airways account for airway narrowing. In this
respect, structural changes of both the large and small airways
have been described by CARROLL et al. [22] in cases of fatal
asthma. The increased thickness of airway wall area resulted
from hypertrophy of all components of the airways (smooth
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muscle, submucosal areas, mucus glands), most likely as a
response of different tissue to airway wall in ammation. These
abnormalities could affect the lung function for geometric
reasons, in that, excessive narrowing occurs for a given degree
of muscle shortening [23]; in addition, the possibility exists
that the increased amount of smooth muscle causes greater
shortening [24]. This phenomenon could be further enhanced
by the interaction between airway smooth muscle and mast
cells. Interestingly, a recent study [25] has demonstrated
increased mast cell in ltration within the airway smooth
muscle, suggesting a key role of these cells in the development
of air ow obstruction, and in the modulation of asthma
severity [26]. Finally, the possibility that increased production
of mucus leads to excess lumen plugging cannot be excluded.
Therefore, different structural abnormalities of the airways
can be selectively associated with the asthmatic phenotype,
and interact to induce airway obstruction. The relationship
between such structural abnormalities and the severity of
asthma, and the selective contribution of small versus large
airway changes to air ow obstruction need further elucidation.
To address the effect of age on the balance between elastase
and a1-PI, two groups of asthmatic subjects of different
ages were compared. Both groups were characterised by a
comparable, though variable, duration of disease (from
7–16 yrs in young asthmatics and from 8–16 in elderly
asthmatics), and a similar degree of functional impairment.
The induced sputum technique was chosen due to its relatively
low invasiveness; indeed, the procedure was well tolerated by
elderly subjects and in no case was the procedure interrupted
because of induction of an asthmatic reaction.
Ageing is associated with structural and functional altera-
tions of the lungs [2, 3, 27]. Lung function deteriorates with
age and is associated with reduction in elastic recoil pressure
[2]. The rearrangement of the elastic  bre network in the lungs
of elderly asthmatics may contribute to reduce the mechanical
interdependence between the airway and the parenchymal
structures, thus leading to excessive airway narrowing. In this
scenario, the structural alterations in lung elasticity associated
with ageing could result in enhanced bronchoconstriction
during an attack of asthma. This is con rmed by recent
observations showing that, despite the same degree of baseline
pulmonary function and airway hyperresponsiveness, elderly
asthmatics have higher bronchial reactivity than young
asthmatics, as expressed by changes in forced vital capacity
[28]. A low-grade in ammation has also been demonstrated in
the airways of many asymptomatic, clinically normal elderly
individuals [11]. Since the neutrophil represents the major
source of elastase in human lung [29], the question is raised
whether the cellular abnormalities of the airways related to
ageing processes, although not clinically evident, could interfere
with the elastolytic activity. In this context, the neutrophil
elastase-a1-proteinase inhibitor complex in bronchoalveolar
lavage  uid was markedly elevated in asymptomatic smokers
[30]; in this population, an accelerated decline in FEV1 was
detected in those subjects who showed higher levels of the
elastase-a1-proteinase inhibitor complex, favouring the hypo-
thesis that neutrophil elastase in the lung is related to the
onset and/or progression of chronic bronchial diseases.
The main result of this study lies in the fact that the levels
of both total and active elastase in the elderly asthmatic
subjects do not differ from those that were found in young
asthmatics, questioning the role that ageing can play as a
factor amplifying neutrophil activation. Thus, these results
imply that age per se does not affect the production of
elastase. Conversely, ageing appears to in uence the cellular-
ity of the induced sputum of elderly healthy subjects. Indeed,
in elderly subjects the percentage of neutrophils was higher
than that of young subjects. The low levels of elastase in
subjects with a high percentage of neutrophils could be
explained with the lack, in healthy subjects, of an activation
step in the production of elastase. An increase in a1-PI levels
was also detected in sputum samples obtained from young
and elderly asthmatic patients compared with control sub-
jects, which may depend on a compensatory response to the
high levels of active elastase, although the former were not
able to counterbalance the increased levels of elastase; in fact,
in both young and elderly asthmatics high amounts of active
elastase still persisted.
Interestingly, the duration of asthma signi cantly affects
the levels of elastase. In the current study in young and elderly
asthmatics, this parameter correlated with the levels of
elastase. Hence, it is likely that the duration of the disease
is the factor that exerts a major in uence on lung function
impairment. As discussed below, the loss of air ow obstruc-
tion reversibility and the decline of lung function can be
explained with permanent and progressive remodelling changes
with age; this would also explain why the functional impair-
ment in asthma is a function of the duration of the disease.
These results con rm previous  ndings obtained by the present
group [31] and are in keeping with a recent study that shows
that, in elderly asthmatics, subjects with asthma of long
duration had a signi cantly lower FEV1 than those with
asthma of a short duration, as well as a greater degree of lung
function decline [32]. In addition, the same study showed that
most subjects with asthma of a long duration failed to achieve
normal air ow after bronchodilator administration, which
indicates that air ow limitation associated with long-term
asthma may become irreversible, and suggests that long-
standing asthma is characterised by an increased extent
of airway remodelling. This concept is also supported by
histopathological studies that demonstrate an increase in
airway wall area, including smooth muscle [22] and airway
narrowing with increasing duration of severe asthma [33].
Therefore, the duration of the disease appears to be the time
variable affecting the baseline airway calibre, independently
of the age of the patient. The signi cant correlation between
the levels of elastase and the duration of asthma supports this
hypothesis and provides novel information on the pathogenic
mechanisms involved in remodelling of the extracellular
matrix in asthmatic subjects.
Finally, the relationship between elastase and the degree of
airway obstruction needs to be explained. Both in young and
in elderly asthmatic subjects, the levels of elastase inversely
correlated with FEV1 values, thus suggesting that, indepen-
dently of age, elastase/a1-PI imbalance may play an important
role in the development of airway obstruction. Taken
together, these  ndings strongly support the concept that, in
the asthmatic condition, the alteration of the mechanisms
involved in the degradation of elastin does not appear to be
enhanced by the process of ageing.
To conclude, this study shows that the imbalance between
elastase and its main inhibitor a1-antitrypsin, as well as the
degree of airway in ammation, is similar in young and elderly
asthmatic subjects, and that the duration of the disease is one
of the major factors implicated in the development of airway
remodelling in asthmatics.
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